1-3 of 3
Eri Fujii
Close
Sort by
Journal Articles

Identification of a Compound Overcoming Drug Resistance of Myeloma Cells at Hypoxic Condition

Eri Fujii, MT, Yuki Inada, Misaki Kakoki, Nao Nishimura, MD, Shinya Endo, MD, Shiho Fujiwara, MD, Naoko Wada, MD, Yawara Kawano, MD PhD, Yutaka Okuno, MD, PhD, Toshiya Sugimoto, MT, Hiroyuki Hata, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5395.
https://doi.org/10.1182/blood.V130.Suppl_1.5395.5395
Published: 2017
Journal Articles

Amyloid Fibril Formation of Immunoglobulin Light Chain Peptide from IHC-Negative AL Amyloidosis and Its Inhibition By Doxycycline and Epigallocatechin

Hiroyuki Hata, MD PhD, Toshiya Sugimoto, MT, Mitsuharu Ueda, MD, PhD, Nao Nishimura, MD, Shinya Endo, Yutaka Okuno, MD, PhD, Taro Yamashita, Konen Obayashi, MD, PhD, Masayoshi Tasaki, PhD, Eri Fujii, MT, Yuuki Inada, Misaki Kakoki, Yukio Ando, MD, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5331.
https://doi.org/10.1182/blood.V130.Suppl_1.5331.5331
Published: 2017
Journal Articles

Deposition of Lambda Chain Constant Region within AL-Amyloid Lesion

Hiroyuki Hata, MD PhD, Masayoshi Tasaki, Konen Obayashi, MD PhD, Taro Yamashita, MD PhD, Yukio Ando, MD PhD, Shinya Endo, MD, Nao Nishimura, MD, Yutaka Okuno, MD PhD, Shiho Fujiwara, MD PhD, Naoko Wada, MD, Eri Fujii, Kennichi Iyama, MD PhD, Hiroaki Mitsuya, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3348.
https://doi.org/10.1182/blood.V124.21.3348.3348
Published: 2014